Health Tech Capitol | Erik Greenfield
7
archive,paged,author,author-egreenfield,author-7,paged-34,author-paged-34,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Author: Erik Greenfield

HealthX Ventures has made a Series A investment in NarrativeDX, an artificial intelligence platform for patient experience, the organization announced recently. “We are excited to work with NarrativeDx to see their innovative artificial intelligence technology reach its full potential,” Managing Partner of HealthX Ventures Mark Bakken...

MADISON, Wis., April 27, 2017 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenues of $48.4 million and completed approximately 100,000 Cologuard tests during the quarter ended March 31, 2017. First-quarter 2017 revenues and completed Cologuard test volume grew 226 percent and 150 percent from the same...

BioForward will play host to the first of its forum series 8-11 a.m. May 11 at the Wisconsin Institutes for Discovery, the organization announced today. According to a release, the half-day forum series is dedicated to showcasing the strength of Wisconsin’s biohealth ecosystem and will feature emerging and...

Cellular Dynamics International announced recently that it has signed a distribution agreement with STEMCELL Technologies and a collaboration agreement with the Harvard Stem Cell Institute (HSCI). According to a release, STEMCELL Technologies will distribute CDI’s iCell catalog of products in North America, Europe and Singapore. Meanwhile, CDI...